Brief: China Regenerative Medicine International says FY net loss HK$184.5 million
17/07/2017 16:02
July 17 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* Group's revenue for year ended 30 April 2017 was
approximately HK$357.0 million versus HK$27.8 million
* Directors do not recommend payment of a dividend for year
ended 30 April 2017
* FY net loss HK$184.5 million versus loss HK$190.9 million
Source text for Eikon: ID:nHKS2YjQYP
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital